MVRx
Clinical Trial Outcomes Show Great Promise for Less-Invasive Therapy to Help Millions of Heart Failure Patients Suffering from Mitral Valve Regurgitation
May 23, 2017 Clinical trial outcomes from the MAVERIC clinical trial confirm earlier positive findings that MVRx’s ARTO System safely and effectively treats mitral valve regurgitation associated with congestive heart failure. The results, presented by leading cardiologists at EuroPCR,...
